Equine protozoal myeloencephalitis (EPM) and West Nile virus (WNV) are two diagnoses that veterinarians don’t want to give and that horse owners dread hearing. To help owners in the United States stay up-to-date on the latest information regarding these devastating diseases, Merck Animal Health has developed two new comprehensive websites, www.protazil.com and www.westnileequinevaccines.com.
The Protazil.com EPM resource center provides owners with:
· Up-to-date disease information and research through webinars, videos, fact sheets, educational brochures, etc.
· News and events surrounding EPM
· Management strategies to aid in prevention of EPM
· Treatment options to discuss with their veterinarians
The website also offers information on Merck Animal Health’s new EPM treatment product, PROTAZIL (diclazuril) 1.56%, the only FDA-approved, alfalfa-based, pelleted EPM treatment product on the market.